Seelos up 7% on advancement of second gene therapy for Parkinson’s

Seelos up 7% on advancement of second gene therapy for Parkinson’s
Nano cap Seelos Therapeutics (SEEL +7%) is up out of the gate this morning in reaction to its update on SLS-007, its second gene therapy candidate for the potential treatment of Parkinson's disease. ... read more
Source: Bing NewsPublished on 2020-01-28